Skip to main content

Find Clinical Trials

Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients

NCT02093754

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: CHU Brussels Brussels, Belgium

Hôpital la Salpêtrière Paris, France

Hôpital Saint Antoine Paris, France

Medical Center for Infectious Diseases Berlin, Germany

View Trial Details

Completed

Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age

NCT01127204

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Service de maladies infectieuses - CHU Charles de Gaulle Ouagadougou, Burkina Faso

Service de pédiatrie - CHU Yalgado Ouedraogo Ouagadougou, Burkina Faso

CEPREF Abidjan, Côte d’Ivoire

FSU abobo-Avocatier Abidjan, Côte d’Ivoire

View Trial Details

Completed

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

NCT01348308

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Hôpital Henri Mondor Créteil, France

View Trial Details

Completed

H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

NCT01111162

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: University of Pennsylvania. Clinical Trials Unit Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Viral Activation Transfusion Study (VATS)

NCT00000593

Conditions: Acquired Immunodeficiency Syndrome, Blood Transfusion, Blood-Borne Infections, +17 more
Locations: Not specified

View Trial Details

Completed

A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

NCT01258101

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Gratwein, Austria

Graz, Austria

Innsbruck, Austria

Linz, Austria

View all 18 locations

View Trial Details

Completed

A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

NCT01458535

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

NCT01899196

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Hospital St Antoine Paris, France

View Trial Details

Completed

A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection

NCT02582983

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Bangkok, Thailand

Bangkok, Thailand

Bangkok, Thailand

Chiang Mai, Thailand

View Trial Details

Completed

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

NCT00087607

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Birmingham, Alabama, United States

Little Rock, Arkansas, United States

Sacramento, California, United States

San Diego, California, United States

View all 41 locations

View Trial Details